Replies to post #776350 on NorthWest Biotherapeutics Inc (NWBO)

[jesster64]

Slave1, do you believe NWBO submitted for multiple cancers or just glioblastoma?

[Investor082]

“company may be pushing for more than originally expected”

—what a load of BS! The company can’t even get approval for nGBM & rGBM with manual manufacturing. Its been 19 months since the submission, and the share price is languishing in the .20s. Only naive retail would fall for that crap!

Come August the share price will be in the teens and in September it will be all time lows, but LP will be pushing for more, LOL!

The reality is that they have received RFIs for many months now and they have not been able to respond to all of those concerns yet. So MHRA is still waiting on NWBO. But continue to BS!

[seekinganswers]

Dear AI bot ,
I never implied it was about Flaskworks, which is years away , at best, if even ever!
My suggestion was that. the delay is about the botched and flawed PIP that LP (somehow) got MHRA to approve before the field clinicians kicked it back with SUBSTANTIAL CHANGES, that have yet to be approved (for a second time) at MHRA, now that everyone seems to be watching!
I walked into nothing, and your ridiculous post is laughable.
And YES the process is real, about as real as the likely rejection that could be forthcoming. IMO